Nvwm, LLC Gilead Sciences, Inc. Transaction History

Nvwm, LLC

$382 Million
Q3 2024

A detailed history of Nvwm, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Nvwm, LLC holds 18 shares of GILD stock, worth $1,656. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 13 38.46%

Holding current value

$1,656

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$66.59 - $83.99 $332 - $419	5 Added 38.46%	18 $1,000
Q2 2024 Aug 13, 2024	SELL	$63.15 - $72.88 $252 - $291	-4 Reduced 23.53%	13 $0
Q1 2024 May 06, 2024	BUY	$71.58 - $87.29 $1,216 - $1,483	17 New	17 $1,000
Q2 2022 Aug 04, 2022	SELL	$57.72 - $65.01 $3,059 - $3,445	-53 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$57.92 - $72.58 $3,069 - $3,846	53 New	53 $3,000
Q1 2021 May 11, 2021	SELL	$60.0 - $68.46 $6,000 - $6,845	-100 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$56.65 - $64.55 $5,665 - $6,455	100 New	100 $6,000
Q2 2020 Aug 11, 2020	SELL	$72.34 - $84.0 $524,682 - $609,252	-7,253 Closed	0 $0
Q1 2020 May 08, 2020	SELL	$62.63 - $80.22 $739,597 - $947,317	-11,809 Reduced 61.95%	7,253 $542,000
Q3 2019 Oct 29, 2019	BUY	$62.51 - $69.0 $1.19 Million - $1.32 Million	19,062 New	19,062 $19,000
Q2 2018 Aug 01, 2018	SELL	$64.88 - $75.68 $401,477 - $468,307	-6,188 Closed	0 $0
Q1 2018 May 17, 2018	BUY	$72.84 - $88.8 $10,124 - $12,343	139 Added 2.3%	6,188 $453,000
Q4 2017 Mar 15, 2018	BUY	$71.15 - $83.52 $430,386 - $505,212	6,049	6,049 $433,000

Others Institutions Holding GILD

# of Institutions

1,926

Shares Held

993M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $115B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nvwm, LLC with notifications on news.

Account